The filing, made under the Irish Takeover Panel rules, shows Trium holds 1,267,609 shares in the pharmaceutical company, comprising 1,237,737 owned securities representing 1.26% and 29,872 ...
London-based Pouly has worked across financial markets for more than 15 years, spanning various hedge fund and execution-based roles. He joins Trium Capital from Boussard & Gavaudan, which he joined ...
DUBLIN - Investment firm Trium Capital LLP has disclosed a 1.16% stake in Avadel Pharmaceuticals PLC, according to a regulatory filing published Friday. The disclosure, made under Irish Takeover Panel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback